Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8694)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 15, 2022 (publication date) through Apr 12, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Costante F, Airola C, Santopaolo F, Gasbarrini A, Pompili M, Ponziani FR. Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows. World J Gastrointest Oncol 2022; 14(9): 1622-1636 [PMID: 36187401 DOI: 10.4251/wjgo.v14.i9.1622] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Costante F, Airola C, Santopaolo F, Gasbarrini A, Pompili M, Ponziani FR. Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows. World J Gastrointest Oncol 2022; 14(9): 1622-1636 [PMID: 36187401 DOI: 10.4251/wjgo.v14.i9.1622] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v14/i9/1622.htm |
| Number | Citing Articles |
| 1 |
Lisi Liu, Xun Duan, Baozhao Ju. Recent advances in non-alcoholic steatohepatitis-associated hepatocellular carcinoma: immune cells, metabolic dysregulation, and therapeutic strategies. Frontiers in Oncology 2026; 15 doi: 10.3389/fonc.2025.1744299
|
| 2 |
Mohamed Salaheldin, Heba Aly, Louis Lau, Shimaa Afify, Mohamed El-Kassas. Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: The Next Threat after Viral Hepatitis. Diagnostics 2023; 13(16): 2631 doi: 10.3390/diagnostics13162631
|
| 3 |
Mazen Elsheikh, Mohamad Ali Ibrahim, Sherry Fares, Megha Bhongade, Karim Adhem, Ximena I. Ramirez‐Morales, Ahmed O. Kaseb, Joseph Petrosino, Manal M. Hassan, Prasun K. Jalal. Influence of Gut Microbiota on Response to Immune Check Point Inhibitors in MASLD Patients With HCC: Unraveling the Connection. Cancer Medicine 2026; 15(4) doi: 10.1002/cam4.71738
|
| 4 |
Hao-Nan Han, Jin-Hu Ma, Jia-Bei Wang, Yao Liu. Immune microenvironment and immunotherapy strategies in MAFLD-related hepatocellular carcinoma. Hepatoma Research 2025; doi: 10.20517/2394-5079.2025.54
|
| 5 |
Francesca Ibba, Carlo Airola, Tommaso Rozera, Lucrezia Petrucci, Giorgio Carlino, Simone Varca, Chiara Cavallaro, Nicoletta De Matthaeis, Fabrizio Pizzolante. Clinical Value of Ultrasound Fat Fraction in Grading Hepatic Steatosis: Preliminary Cut-Off Values in Obese Patients. Gastroenterology Insights 2025; 16(4): 47 doi: 10.3390/gastroent16040047
|
| 6 |
Jian Yang, Jialuo He, Yiting Feng, Ming Xiang. Obesity contributes to hepatocellular carcinoma development via immunosuppressive microenvironment remodeling. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1166440
|
| 7 |
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations. Journal of Clinical and Experimental Hepatology 2024; 14(1): 101269 doi: 10.1016/j.jceh.2023.08.005
|
| 8 |
Min Dai, Rashid N. Lui, Louis H.S. Lau. The role of gut microbiome and fecal microbiota transplantation in liver cancer and related complications: mechanisms and therapeutic potentials. Hepatoma Research 2023; doi: 10.20517/2394-5079.2023.33
|
| 9 |
Chi Zhang, Huihui Shao, Zunsheng Han, Bo Liu, Jing Feng, Jie Zhang, Wenxuan Zhang, Kun Zhang, Qingyun Yang, Song Wu. Development and In Vitro–In Vivo Correlation Evaluation of IMM-H014 Extended-Release Tablets for the Treatment of Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(15): 12328 doi: 10.3390/ijms241512328
|
| 10 |
Kassandra Ofelia Rodríguez-Aguillón, Mónica Lizeth González-González, Kenny Misael Calvillo-Rodríguez, Cristina Rodríguez-Padilla, Ana Carolina Martínez-Torres. The impact of chronic comorbidities on cancer immunoediting: challenges and opportunities for immunotherapies. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1773872
|
| 11 |
Mehmet Akce, Bassel F El-Rayes, Narendra Wajapeyee. Combinatorial targeting of immune checkpoints and epigenetic regulators for hepatocellular carcinoma therapy. Oncogene 2023; 42(14): 1051 doi: 10.1038/s41388-023-02646-1
|